Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes

被引:57
|
作者
Nomura, Takuo [1 ]
Ishiguro, Tomoyasu [2 ]
Ohira, Masayoshi [3 ]
Ikeda, Yukio [4 ]
机构
[1] Kansai Univ Welf Sci, Dept Rehabil Sci, Osaka, Japan
[2] Hlth Sci Univ, Dept Phys Therapy, Yamanashi, Japan
[3] Shinshu Univ, Sch Hlth Sci, Nagano, Japan
[4] Kochi Mem Hosp, Ctr Diabet, Kochi, Japan
来源
JOURNAL OF DIABETES INVESTIGATION | 2018年 / 9卷 / 01期
基金
日本学术振兴会;
关键词
Diabetic neuropathy; Muscle strength; Type; 2; Diabetes; MUSCLE STRENGTH; BODY-COMPOSITION; SKELETAL-MUSCLE; OLDER-ADULTS; HEALTH; NEUROPATHY; QUALITY; PEOPLE; POWER;
D O I
10.1111/jdi.12658
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/IntroductionThe present study elucidated the effect of diabetic polyneuropathy (DPN) on lower extremity strength in a wide age range of type 2 diabetes patients. Materials and MethodsParticipants (n=1,442) were divided into three age groups (30-49years, 50-69years and 70-87years), and comparisons were made separately for each sex. Lower extremity strength was measured in terms of knee extension force (KEF) with a hand-held dynamometer. KEF was compared according to the presence or absence of DPN. Furthermore, the effect of DPN on KEF with other diabetic complications (diabetic retinopathy and diabetic nephropathy), diabetes status (diabetes duration and glycated hemoglobin) and habitual behavior (regular exercise, smoking and drinking behaviors) as explanatory variables was analyzed using multiple regression analysis in several models. ResultsThe frequency of DPN differed among age groups, ranging from 14.3 to 49.6%, and increasing with age. There was no significant difference in KEF between patients aged 30-49years with and without DPN. However, among both men and women aged 50-69years and 70-87years, patients with DPN showed significantly diminished KEF (11.0-12.9% and 11.9-16.6%, respectively) compared with those without DPN (P<0.01-0.001). In women aged 50-69years and 70-87years, and in men aged 50-69years, DPN was a significant explanatory variable for KEF in all multiple regression analysis models. ConclusionDPN might reinforce a KEF decline in middle-aged and elderly type 2 diabetes patients.
引用
收藏
页码:186 / 192
页数:7
相关论文
共 50 条
  • [21] Lipid parameters and risk of diabetic polyneuropathy in type 2 diabetes: a Danish cohort study
    Kristensen, F. P. B.
    Christensen, D. H.
    Callaghan, B. C.
    Sorensen, H. T.
    Thomsen, R. W.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S106 - S107
  • [22] Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients
    Speckman, RA
    Frankenfield, DL
    Roman, SH
    Eggers, PW
    Bedinger, MR
    Rocco, MV
    McClellan, WM
    DIABETES CARE, 2004, 27 (09) : 2198 - 2203
  • [23] Obesity - a risk factor for diabetic retinopathy in type 2 diabetes?
    Katusic, D
    Tomic, M
    Jukic, T
    Kordic, R
    Sikic, J
    Vukojevic, N
    Saric, B
    COLLEGIUM ANTROPOLOGICUM, 2005, 29 : 47 - 50
  • [24] Anemia is a risk factor for rapid eGFR decline in type 2 diabetes
    Xie, Lijie
    Shao, Xiaoqing
    Yu, Yifei
    Gong, Wei
    Sun, Fei
    Wang, Meng
    Yang, Yeping
    Liu, Wenjuan
    Huang, Xinmei
    Wu, Xia
    Wu, Huihui
    Li, Yiming
    Zhang, Zhaoyun
    Wen, Jie
    He, Min
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [25] Plasma Copeptin and Risk for Lower Extremity Amputation in People with Type 1 and Type 2 Diabetes
    Potier, Louis
    Roussel, Ronan
    Mohammedi, Kamel
    Saulnier, Pierre
    Marre, Michel
    Hadjadj, Samy
    Velho, Gilberto
    DIABETES, 2019, 68
  • [26] Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes
    Potier, Louis
    Roussel, Ronan
    Marre, Michel
    Bjornstad, Petter
    Cherney, David Z.
    El Boustany, Ray
    Fumeron, Frederic
    Venteclef, Nicolas
    Gautier, Jean-Francois
    Hadjadj, Samy
    Mohammedi, Kamel
    Velho, Gilberto
    DIABETES CARE, 2019, 42 (12) : 2290 - 2297
  • [27] Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy
    Stoian, Adina
    Bacarea, Anca
    Motataianu, Anca
    Stoian, Mircea
    Gliga, Florina
    Bacarea, Vladimir
    Carmen, Duicu
    Banescu, Claudia
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2014, 22 (02): : 165 - 172
  • [28] High-resolution color doppler ultrasound examination and related risk factor analysis of lower extremity vasculopathy in type 2 diabetes patients
    Xu, J.
    Wang, G.
    Fu, D.
    Su, N.
    Wang, L.
    Gao, F.
    Guo, N.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 3939 - 3947
  • [29] Prognostic factors for amputation on lower extremity in patients with type 2 diabetes mellitus
    Vakhrusheva, T. V.
    Basyreva, L. Y.
    Gusev, S. A.
    Maximov, D. I.
    Ostrovsky, E. M.
    Panasenko, O. M.
    Fyodorova, E.
    Mikhalchik, E.
    FEBS OPEN BIO, 2021, 11 : 448 - 448
  • [30] LIPOPROTEIN(A) AS A RISK FACTOR IN TYPE 2 DIABETIC PATIENTS
    Makino, K.
    Kato, A.
    Watanabe, I.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 261 - 261